- The Effect of Long-Term Atorvastatin Therapy on Carotid Intima-Media Thickness of Children With Dyslipidemia
Angiology · 2020
- A pilot randomized trial of atorvastatin as adjunct therapy in patients with acute venous thromboembolism
Blood Coagulation & Fibrinolysis · 2020
- The effects of melatonin against atherosclerosis-induced endothelial dysfunction and inflammation in hypercholesterolemic rats
Archives of Physiology and Biochemistry · 2020
- Pharmacokinetics and Pharmacogenetics of Apixaban
Rational Pharmacotherapy in Cardiology · 2020
- Chronic ischaemic heart disease and rivaroxaban: which patients derive the greatest benefit?
European Heart Journal Supplements · 2020
- Reduction of epicardial adipose tissue thickness with PCSK9 inhibitors
European Heart Journal · 2020
- Cardiovascular and safety events of PCSK9 inhibitors in statin-treated patients with cardiovascular risk: A Systematic Review and Meta-Analysis
Journal of Pharmacy & Pharmaceutical Sciences · 2020
- Atrial Fibrillation and Use of Rivaroxaban: Performance of the Prothrombin Time / INR as a Function of Time After Blood Collection
International Journal of Cardiovascular Sciences · 2020
- The impact of atorvastatin on dabigatran plasma levels in patients with atrial fibrillation
Blood Coagulation & Fibrinolysis · 2020
- Clinical implications of the log linear association between LDL-C lowering and cardiovascular risk reduction: Greatest benefits when LDL-C >100 mg/dl
PLoS ONE · 2020
- Atrial nitroso-redox balance and refractoriness following on-pump cardiac surgery: a randomized trial of atorvastatin
Cardiovascular Research · 2020
- Rivaroxaban versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients with Non-Valvular Atrial Fibrillation
University Heart Journal · 2020
- PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36
Circulation · 2020
- Anticoagulant activity of apixaban can be estimated by multiple regression analysis
Journal of Arrhythmia · 2020
- Lipoprotein apheresis and PCSK9 inhibitors for severe familial hypercholesterolaemia: Experience from Australia and New Zealand
Journal of Clinical Apheresis · 2020
- 99m Tc‐labeled Duramycin for detecting and monitoring cardiomyocyte death and assessing atorvastatin cardioprotection in acute myocardial infarction
Chemical Biology & Drug Design · 2020
- Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia
New England Journal of Medicine · 2020
- Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia
Journal of Clinical Hypertension · 2020
- Heart Valves Cross-Linked with Erythrocyte Membrane Drug-Loaded Nanoparticles as a Biomimetic Strategy for Anti-coagulation, Anti-inflammation, Anti-calcification, and Endothelialization
ACS Applied Materials & Interfaces · 2020
- Reversal of rivaroxaban anticoagulant effect by prothrombin complex concentrates: which dose is sufficient to restore normal thrombin generation?
Thrombosis Journal · 2020
- Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy
JAMA Cardiology · 2020
- The effect of direct oral anticoagulants on blood protein C activity
2020
- Efficiency Of Atorvastatin On In-Hospital Mortality Of Patients With Acute Aortic Dissection (Aad): Study Protocol For A Randomized, Double-Blind, Placebo-Controlled Trial
2020
- Platelet reactivity with a third generation thienopyridine drug versus with a second-generation thienopyridine drug
International Journal of Research in Pharmaceutical Sciences · 2020
- Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice
Arteriosclerosis Thrombosis and Vascular Biology · 2020
- Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy
Frontiers in Pharmacology · 2020
- Serious adverse events and deaths in PCSK9 inhibitor trials reported on ClinicalTrials.gov: a systematic review
Expert Review of Clinical Pharmacology · 2020
- Inferior Vena Cava Filter Thrombus in the Patient with Chronic Venous Thromboembolism under Continuous Warfarin Therapy: A Case Report
The Japanese Journal of Phlebology · 2020
- Efficacy and tolerability of alirocumab in Austrian clinical practice – results of the non-interventional PEARL-AT study
Current Medical Research and Opinion · 2020
- Combination of Dichloroacetate and Atorvastatin Regulates Excessive Proliferation and Oxidative Stress in Pulmonary Arterial Hypertension Development via p38 Signaling
Oxidative Medicine and Cellular Longevity · 2020
- Successful Resolution of a Large Left Ventricular Thrombus with Rivaroxaban
CASE · 2020
- A Pilot Randomized Study of Atorvastatin As Adjunct Therapy in Patients with Acute Venous Thromboembolism
2020
- Efficacy of statin treatment based on cardiovascular outcomes in elderly patients: a standard meta-analysis and Bayesian network analysis
Journal of International Medical Research · 2020
- Lipoprotein(a) in atherosclerosis: from pathophysiology to clinical relevance and treatment options
Annals of Medicine · 2020
- Comparing effectiveness of high-dose Atorvastatin and Rosuvastatin among patients undergone Percutaneous Coronary Interventions: A non-concurrent cohort study in India
PLoS ONE · 2020
- Atorvastatin attenuates TGF‑β1‑induced fibrogenesis by inhibiting Smad3 and MAPK signaling in human ventricular fibroblasts
International Journal of Molecular Medicine · 2020
- Safety of Candesartan, Amlodipine, and Atorvastatin in Combination: Interaction Study in Healthy Subjects
Clinical Pharmacology in Drug Development · 2020
- Strengthening effects of bone marrow mononuclear cells with intensive atorvastatin in acute myocardial infarction
Open Heart · 2020
- An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial
JAMA Cardiology · 2020
- Homozygous familial hypercholesterolemia: what treatments are on the horizon?
Current Opinion in Lipidology · 2020
- Highly effective lipid-lowering therapy on local vascular stiffness and symptoms of chronic heart failure in patients with postinfarction cardiosclerosis
Arterial’naya Gipertenziya (Arterial Hypertension) · 2020
- Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies
European Journal of Preventive Cardiology · 2020
- New Paradigms of Extended Thromboprophylaxis in Medically Ill Patients
Journal of Clinical Medicine · 2020
- Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome
Circulation · 2020
- The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
Circulation · 2020
- Comparison of Clinical and Biochemical Parameters in Atrial Fibrillation Patients Using Dabigatran and Rivoraxaban and Their Relationship with Complications
İstanbul Medical Journal · 2020
- Latent opportunities for the prevention of ischemic stroke in patients with atherosclerosis-related diseases: additional analysis of randomized trials on rivaroxaban
Russian Journal of Cardiology · 2020
- Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST‐elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI)
Drug Development Research · 2020
- Current status of rivaroxaban in elderly patients with pulmonary embolism (Review)
Experimental and Therapeutic Medicine · 2020
- Direct-acting Anticoagulants in Chronic Coronary Syndromes
European Cardiology Review · 2020